FTDI
ENTA icon

First Trust Direct Indexing’s Enanta Pharmaceuticals ENTA Stock Holding History

First Trust Direct Indexing’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,829
Closed -$119K – 568
2020
Q4 		$119K Buy
+2,829
New +$124K 0.03% 454

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

First Trust Direct Indexing's ENTA Position: Q1 2021 in Review

First Trust Direct Indexing sold out of Enanta Pharmaceuticals (ENTA) in Q1 2021, closing a stake of 2,829 shares — an estimated $119K sold.

First Trust Direct Indexing first reported a position in ENTA in Q4 2020 and held it in 1 quarter. The position peaked at $119K in Q4 2020. 148 funds tracked by Wall St. Rank hold ENTA as of Q1 2021.

  • First Trust Direct Indexing reported no remaining Enanta Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • First Trust Direct Indexing sold 2,829 Enanta Pharmaceuticals shares in Q1 2021, an estimated $119K.
  • First Trust Direct Indexing first reported a position in Enanta Pharmaceuticals in Q4 2020 and held it in 1 quarter.
  • First Trust Direct Indexing's Enanta Pharmaceuticals position peaked at $119K in Q4 2020.
  • 148 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2021.

Based on First Trust Direct Indexing's 13F filing for Q1 2021, filed 14 Apr 2021.